Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chromosomal Variations Found in Early Passage Female Human Embryonic Stem Cell Lines

28.06.2010
Human embryonic stem cells hold great promise for studying and treating disease and for the practice of regenerative medicine. However, more must be learned to ensure the cells that may one day be transplanted into humans are safe.

In one of many safety-related studies going on worldwide, scientists at the UCLA Broad Stem Cell Research Center have uncovered that variations in X chromosome inactivation take place in very early passages of female human embryonic stem cells lines, information that will play an important role in ensuring the safety of cells grown for therapeutic use and a discovery that also may have implications in the development of cancer.

Chromosomal and genetic variations found in human embryonic stem cells lines have been attributed, in large part, to the various culture conditions in which they’re grown, said Tamar Dvash, first author of the study and a postdoctoral fellow at UCLA.

However, the work by the Broad Stem Cell Research Center scientists reveals that very early in their growth, female human embryonic stem cells already show variation in the inactivation of the X chromosome.

“It suggests that culture conditions and methods in the derivation of human embryonic stem cells could be further improved to achieve a uniform pattern of X chromosome inactivation,” said Guoping Fan, an associate professor of human genetics and senior author of the study.

The study is published June 25, 2010 in the early online edition of the journal PLoS ONE, a publication of the Public Library of Science.

All female cells have two X chromosomes and in early development, one X chromosome is permanently inactivated. The X chromosome inactivation ensures that females, like males, have one functional copy of the X chromosome in each body cell and that the cells develop normally. If the second X chromosome is not inactivated, the result could be disease development, including some cancers in which two active X chromosomes can be found in the malignant cells, Dvash said.

Previously, what scientists knew about human embryonic development was gleaned from studying mouse embryos. However, the advent of human embryonic stem cell research has allowed researchers to closely study early human development. Dvash, Fan and other scientists, including collaborator Neta Lavon of Cedars-Sinai Medical Center, were examining the process of inactivation of the X chromosome when they made their observation.

The creation of a stem cell line includes many steps. The donated, frozen blastocysts are thawed and the inner cell mass – the 20 to 50 cells that are fully pluripotent in the blastocyst - is placed in culture with cells that support its growth. After a time, a small piece of the developing stem cell colony, or group of cells, is cut away and placed into a culture dish to further expand, a process called passaging.

The cells studied by Dvash and Fan were passaged only five to ten times instead of the usual more than 20 times, meaning the culture in which they were grown should have had less influence on any variation found in the cells. However, even at the first five passages, the resulting cells showed variations in X chromosome inactivation, meaning some cells had inactivated one X chromosome and some had not.

“People are looking at these cells as having great potential for transplantation and possible cures for diseases,” Dvash said. “What this study proves is that we need to monitor X chromosome inactivation closely in cells being considered for therapeutic use. We need to make sure they’re undergoing normal inactivation to ensure they will be stable when they begin to differentiate.”

Going forward, the scientists will also examine induced pluripotent stem cells, adult stem cells that have been reprogrammed to have all the qualities of embryonic stem cells, which can become any cell in the body. They will study skin cells taken from females, which would already have undergone inactivation of one X chromosome because they are already differentiated. The cells will be programmed into embryonic-like cells with two active X chromosomes so they can more closely study the process of inactivation.

“We want to know how does it happen and when,” Dvash said.

This study was funded by two grants from the California Institute of Regenerative Medicine, the state’s stem cell research agency.

The stem cell center was launched in 2005 with a UCLA commitment of $20 million over five years. A $20 million gift from the Eli and Edythe Broad Foundation in 2007 resulted in the renaming of the center. With more than 200 members, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research is committed to a multi-disciplinary, integrated collaboration of scientific, academic and medical disciplines for the purpose of understanding adult and human embryonic stem cells. The center supports innovation, excellence and the highest ethical standards focused on stem cell research with the intent of facilitating basic scientific inquiry directed towards future clinical applications to treat disease. The center is a collaboration of the David Geffen School of Medicine, UCLA’s Jonsson Cancer Center, the Henry Samueli School of Engineering and Applied Science and the UCLA College of Letters and Science. To learn more about the center, visit our web site at http://www.stemcell.ucla.edu. To learn more about the center, visit our web site at http://www.stemcell.ucla.edu

Kim Irwin | Newswise Science News
Further information:
http://www.stemcell.ucla.edu

More articles from Life Sciences:

nachricht What the world's tiniest 'monster truck' reveals
23.08.2017 | American Chemical Society

nachricht Treating arthritis with algae
23.08.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>